key: cord-0709025-t9o1yldo
authors: Makhoul, Kamal; Shukha, Yousef; Abu Hanna, Lana; Nitecki, Samy; Leiderman, Maxim; Hayek, Tony; Hamoud, Shadi
title: A Case of Rapidly Progressive Upper Limb Ischemic Necrosis in a Patient with COVID-19
date: 2021-04-20
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.04.023
sha: a1ea751ca2d2357614ebf2a82e3b5f8f21663268
doc_id: 709025
cord_uid: t9o1yldo

AIM: For more than one year the health systems all over the world are combating the global Corona virus disease 2019 (COVID-19) pandemic, cased by a novel Corona virus (N-COV) which was first described in Wuhan city, China, presenting as an atypical infection of the lower respiratory tract. METHODS: COVID-19 is characterized by multisystemic involvement, and mortality is attributed mainly to the respiratory system involvement, which may lead to severe acute respiratory distress syndrome and respiratory failure. Several COVID-19 associated complications are being increasingly reported, among which arterial and venous thromboembolic events, that may lead to amputation of affected limbs. So far, a large number of reports have described hypercoagulability crises leading to amputation of lower limbs, while the National Library of Medicine (Medline) search revealed no cases of urgent upper limb amputation in COVID-19 patients. RESULTS: We here describe for the first time in literature, a case of upper limb ischemia in a COVID-19 patient, with rapid progression to hand necrosis, requiring urgent through-arm amputation of the upper limb. CONCLUSIONS: Our case emphasizes the need for anticoagulant therapy in COVID-19 patients, and keeping in mind to stay aware for the possible thromboembolic COVID-19 related sequelae.

Since December 2019, the world health organization is facing a global pandemic caused by a novel corona virus (N-COV), named Corona virus disease 19 (COVID-19), which was first described in a cluster of subjects that presented with atypical pneumonia in Hubei province in China. Up to March 18, 2021, about 122 million people were affected by the N-COV worldwide, with more than 2.6 million deaths.

The clinical presentation of COVID-19 falls in the spectrum of an asymptomatic condition to a rapidly progressive fatal disease, which may result from multi-organ failure, mainly involving the respiratory system. Common symptoms include high-grade fever, throat pain, loss of smell and taste sensations, dry cough, headache, and myalgia. Typical laboratory findings include elevated C-reactive protein, lymphopenia, and high D-dimer levels which reflect exuberant inflammatory process and endothelial injury, that is believed to be the etiology for venous and arterial therombo-embolic phenomena which frequently occur in COVID-19 subjects (1) . Also renal function impairment and elevated liver enzymes are largely reported. Diffuse pulmonary infiltrates are the characteristic radiologic findings observed in hospitalized patients. We hereby report a case of severe upper limb ischemia with rapid progression to necrosis of the hand and the distal forearm in a COVID-19 patient, necessitating urgent amputation of her upper limb.

A 50-years-old female tested positive for COVID-19 three days prior to her admission, was referred with fatigue, nausea, abdominal pain and elevated blood glucose measurements. Her past medical history was remarkable for hypertension, dyslipidemia, type I diabetes mellitus, chronic kidney disease and monoclonal gammopathy of undetermined significance. Her vital signs on admission were normal and physical examination was unremarkable. She had normal peripheral arterial pulsations in her four limbs. Laboratory workup revealed hyperglycemia of 928 mg/dl, Due to rapidly deteriorating severe ischemia with hand necrosis despite full-dose heparin treatment (Figure 3) , through forearm amputation of the right upper extremeity was performed two days following onset of symptoms. Following amputation, the amputee appeared well vascularized, and the left hand swelling didn't deteriorate nor appeared ischemic. 

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management

Acute limb ischemia in patients with COVID-19 pneumonia

COVID-19: the vasculature unleashed

Severe COVID-19 Is a Microvascular Disease

Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Unusual arterial thrombotic events in Covid-19 patients

Acute upper limb ischemia in a patient with COVID-19